- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Erschienen in
-
In: Frontiers in Aging Neuroscience 8:196. doi: 10.3389/fnagi.2016.00196
- Ereignis
-
Veröffentlichung
- (wo)
-
Würzburg
- (wer)
-
Universität Würzburg
- (wann)
-
2018
- Urheber
-
Isaias, Ioannis U.
Trujillo, Paula
Summers, Paul
Marotta, Giorgio
Mainardi, Luca
Pezzoli, Gianni
Zecca, Luigi
Costa, Antonella
- URN
-
urn:nbn:de:bvb:20-opus-164046
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:24 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Isaias, Ioannis U.
- Trujillo, Paula
- Summers, Paul
- Marotta, Giorgio
- Mainardi, Luca
- Pezzoli, Gianni
- Zecca, Luigi
- Costa, Antonella
- Universität Würzburg
Entstanden
- 2018
Ähnliche Objekte (12)
Presynaptic dopaminergic terminal imaging and non-motor symptoms assessment of Parkinson’s disease: evidence for dopaminergic basis?
Loss of Drosha underlies dopaminergic neuron toxicity in models of Parkinson’s disease
Cav2.3 channels contribute to dopaminergic neuron loss in a model of Parkinson’s disease
Parkinson’s Disease, the Dopaminergic Neuron and Gammahydroxybutyrate
IGF2 prevents dopaminergic neuronal loss and decreases intracellular alpha-synuclein accumulation in Parkinson’s disease models
Dopaminergic neuron metabolism: relevance for understanding Parkinson’s disease
Long-term hyperglycemia aggravates α-synuclein aggregation and dopaminergic neuronal loss in a Parkinson’s disease mouse model
Curcumin inhibition of JNKs prevents dopaminergic neuronal loss in a mouse model of Parkinson’s disease through suppressing mitochondria dysfunction
Epigenetic Dynamics in Reprogramming to Dopaminergic Neurons for Parkinson's Disease
Motivational modulation of bradykinesia in Parkinson’s disease off and on dopaminergic medication
Gastrodin protects dopaminergic neurons via insulin-like pathway in a Parkinson’s disease model
Unraveling connectivity changes due to dopaminergic therapy in chronically treated Parkinson’s disease patients
Presynaptic dopaminergic terminal imaging and non-motor symptoms assessment of Parkinson’s disease: evidence for dopaminergic basis?
Loss of Drosha underlies dopaminergic neuron toxicity in models of Parkinson’s disease
Cav2.3 channels contribute to dopaminergic neuron loss in a model of Parkinson’s disease
Parkinson’s Disease, the Dopaminergic Neuron and Gammahydroxybutyrate
IGF2 prevents dopaminergic neuronal loss and decreases intracellular alpha-synuclein accumulation in Parkinson’s disease models
Dopaminergic neuron metabolism: relevance for understanding Parkinson’s disease
Long-term hyperglycemia aggravates α-synuclein aggregation and dopaminergic neuronal loss in a Parkinson’s disease mouse model
Curcumin inhibition of JNKs prevents dopaminergic neuronal loss in a mouse model of Parkinson’s disease through suppressing mitochondria dysfunction
Epigenetic Dynamics in Reprogramming to Dopaminergic Neurons for Parkinson's Disease
Motivational modulation of bradykinesia in Parkinson’s disease off and on dopaminergic medication
Gastrodin protects dopaminergic neurons via insulin-like pathway in a Parkinson’s disease model
Unraveling connectivity changes due to dopaminergic therapy in chronically treated Parkinson’s disease patients
Presynaptic dopaminergic terminal imaging and non-motor symptoms assessment of Parkinson’s disease: evidence for dopaminergic basis?
Loss of Drosha underlies dopaminergic neuron toxicity in models of Parkinson’s disease
Cav2.3 channels contribute to dopaminergic neuron loss in a model of Parkinson’s disease
Parkinson’s Disease, the Dopaminergic Neuron and Gammahydroxybutyrate
IGF2 prevents dopaminergic neuronal loss and decreases intracellular alpha-synuclein accumulation in Parkinson’s disease models
Dopaminergic neuron metabolism: relevance for understanding Parkinson’s disease
Long-term hyperglycemia aggravates α-synuclein aggregation and dopaminergic neuronal loss in a Parkinson’s disease mouse model
Curcumin inhibition of JNKs prevents dopaminergic neuronal loss in a mouse model of Parkinson’s disease through suppressing mitochondria dysfunction
Epigenetic Dynamics in Reprogramming to Dopaminergic Neurons for Parkinson's Disease
Motivational modulation of bradykinesia in Parkinson’s disease off and on dopaminergic medication
Gastrodin protects dopaminergic neurons via insulin-like pathway in a Parkinson’s disease model